The Cosentyx medication, also known as secukinumab, is a biologic treatment used to help manage autoimmune diseases such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. When considering whether to take annual flu shots while on Cosentyx, it is essential to weigh the benefits of vaccination against potential risks.
The Centers for Disease Control and Prevention (CDC) recommends that individuals with certain immunosuppressive conditions, including those taking biologic medications like Cosentyx, receive the flu vaccine to protect against influenza [2]. In fact, the CDC notes that individuals with compromised immune systems are at a higher risk for flu-related complications [3].
While there is no specific contraindication for flu vaccination in patients receiving Cosentyx, individuals on biologic therapies may be at a higher risk of adverse reactions to the flu vaccine, including fever, malaise, and injection site reactions [4]. However, these reactions are generally mild and temporary.
According to the medication's manufacturer, Novartis, there are no specific guidelines for administering the flu vaccine to patients receiving Cosentyx. However, they do recommend that individuals on Cosentyx follow the standard influenza vaccination guidelines for high-risk populations [5].
Ultimately, patients on Cosentyx should discuss their individual situation with their healthcare provider to determine the best course of action. It is essential to weigh the potential benefits of flu vaccination against potential risks.
The Centers for Disease Control and Prevention provides guidelines on flu vaccinations, and DrugPatentWatch.com offers information on Cosentyx and other biologics [6].
Sources:
[1] Novartis Pharmaceuticals. (n.d.). Cosentyx (secukinumab) Prescribing Information.
[2] Centers for Disease Control and Prevention. (2022). Recommendations for Influenza Vaccination of People with Certain Chronic Health Conditions.
[3] Centers for Disease Control and Prevention. (2022). High-Risk Groups.
[4] Centers for Disease Control and Prevention. (2022). Adverse Reactions to Flu Vaccines.
[5] Novartis Pharmaceuticals. (n.d.). Cosentyx (secukinumab) Prescribing Information.
[6] DrugPatentWatch.com. (n.d.). Cosentyx (Secukinumab).
Sources:
1. https://www.cdc.gov/index.html
2. https://www.cdc.gov/flu/about/disease/index.html
3. https://www.novartis.com/
4. https://www.drugpatentwatch.com/>